dermatan sulfate has been researched along with Genetic Predisposition in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pashkuleva, I; Reis, RL; Soares da Costa, D | 1 |
| Piepenbrock, S; Rahe-Meyer, N; Raymondos, K; Weilbach, C | 1 |
1 review(s) available for dermatan sulfate and Genetic Predisposition
| Article | Year |
|---|---|
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders.
Topics: Chondroitin Sulfates; Congenital Abnormalities; Dermatan Sulfate; Evidence-Based Medicine; Genetic Predisposition to Disease; Glycosaminoglycans; Heparitin Sulfate; Humans; Metabolic Diseases | 2017 |
1 other study(ies) available for dermatan sulfate and Genetic Predisposition
| Article | Year |
|---|---|
Delivery of a healthy child 30 weeks after resuscitation for thromboembolism and treatment with danaparoid: 5-year follow up.
Topics: Anticoagulants; Cardiotonic Agents; Child Development; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Dobutamine; Factor V; Female; Follow-Up Studies; Genetic Predisposition to Disease; Gestational Age; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Mutation; Norepinephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Respiration, Artificial; Vasoconstrictor Agents | 2006 |